Log In
BCIQ
Print this Print this
 

ALD306

  Manage Alerts
Collapse Summary General Information
Company Alder BioPharmaceuticals Inc.
DescriptionHumanized mAb against proprotein convertase subtilisin/kexin type 9 (PCSK9)
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationDyslipidemia
Indication DetailsTreat cardiovascular dyslipidemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today